Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore

Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore

By: IPP Bureau

Last updated : March 14, 2026 3:50 pm



Remidex manufactures micronutrient premixes and nutraceuticals,


Jubilant Ingrevia Limited signed a Share Purchase Agreement to acquire 100% equity stake in Remidex Pharma Private Limited for Rs 16.5 crore cash consideration, making it a wholly owned subsidiary.

Bangalore-based Remidex, incorporated June 15, 1981, manufactures micronutrient premixes, nutraceuticals, and serves as contract manufacturer for Indian/multinational pharma firms. FY25 turnover Rs 24.27 crore with WHO-GMP, FSSC, FSSAI certified facility.

The non-related party acquisition advances Jubilant Ingrevia up the human nutrition value chain from vitamins (B3, B4) leadership into premixes, targeting completion within 30 days.

micronutrient nutraceuticals Jubilant Ingrevia Remidex Pharma

First Published : March 14, 2026 12:00 am